<DOC>
	<DOCNO>NCT00891618</DOCNO>
	<brief_summary>The goal clinical research study learn give acupuncture patient lymphoma plasma cell dyscrasia help relieve numbness and/or tingle foot and/or hand related chemotherapy .</brief_summary>
	<brief_title>Acupuncture Chemo-Induced Peripheral Neuropathy</brief_title>
	<detailed_description>Acupuncture : Acupuncture involve insertion small , solid , sterile needle specific point skin . In study , needle place area intend help relieve numbness tingle foot hand . Weak electrical stimulation also apply needle try improve treatment effect acupuncture . Acupuncture Sessions : Your first acupuncture session day test describe , possible . ( If , schedule another day 10 day screen visit . ) You acupuncture session 3 time per week 4 week ( Weeks 1-4 ) . You 1 week ( Week 5 ) . After , acupuncture session twice per week 4 week ( Weeks 6-10 ) . This total 20 session . In addition 20 planned session , may also choose receive optional 21st acupuncture session end-of-study visit schedule Week 13 . For session , place comfortable position study doctor/acupuncturist find point body needle place . All study participant needle place point body ( hand , foot , leg , abdomen , scalp ) . Very thin , solid , sterile , stainless steel needle use . All needle specially make acupuncture . The depth needle skin number needle use base standard acupuncture procedure . The needle remain place 20-30 minute . Electrical stimulation add needles foot hand . This involve place wire needle , connect machine delivers weak electrical current wire . The strength electrical current change slowly comfortable level . Study Procedures : At session , receive acupuncture , follow procedure perform : - Your vital sign measure . - You ask drug may take side effect may experience . - The color coat tongue quality pulse record . Once week , also ask complete 3 questionnaire begin study . Most study visit last 1 hour . On week complete questionnaire , may add 15-20 minute . During study , may still receive regular pain treatment . If receive Neurontin ( gabapentin ) , Cymbalta ( duloxetine ) , and/or Lyrica ( pregabalin ) , must stay drug ( ) go study . Minor change dos pain treatment allow , large change , take study early . Length Study Participation : You may receive 21 acupuncture session 13 week . If intolerable side effect symptoms occur , take study early . End-of-Study Visit : At Week 13 , go study early reason , end-of-study visit . If doctor think necessary , follow procedure perform : - Your medical history record . - Your vital sign measure . - You ask drug may take side effect may experience . - You complete 3 questionnaire . - The 4 nerve test repeat order learn change nerve function . - Your tongue pulse evaluate . After end-of-study visit , participation study . This investigational study . The acupuncture needle use study commercially available FDA approve . It consider experimental , however , use acupuncture treat numbness and/or tingle foot and/or hand related chemotherapy . Up 30 patient take part study . All enrol The University Texas ( UT ) MD Anderson Cancer Center .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>1 . Patients , legal guardian patient , must ability understand English , sign write informed consent document , willing follow protocol requirement . 2 . Age &gt; 18 year diagnosis plasma cell dyscrasia lymphoma . 3 . Patients must neuropathy great equal 2 accord Common Terminology Criteria Adverse Events ( CTCAE ) , Version 3.0 scale spite previous treatment Neurontin , Cymbalta and/or Lyrica . Patients receive drug must remain medication throughout study period ; however , minor adjustment dosage allow . Patients remove study change type medication necessary . All patient receive treatment upper low extremity , regardless whether experience symptom four extremity . ) 4 . The patient 's previous chemotherapy treatment must include thalidomide and/or bortezomib and/or derivative . 5 . Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 , 1 , 2 . 6 . If patient woman childbearing potential , must negative urine pregnancy test agree use contraception . 1 . Current active treatment thalidomide and/or bortezomib . 2 . Local infection near acupuncture site . ( Although acupuncture minimally invasive procedure , patient exclude indication infection . ) 3 . Deformities could interfere accurate acupuncture point location energy pathway define traditional acupuncture theory . 4 . Concurrent use alternative medicine herbal agent , high dose vitamin anticoagulation agent . 5 . Known coagulopathy take heparin ( include low molecular weight heparin ) Coumadin dose . Patients aspirin nonsteroidal antiinflammatories allow participate . 6 . Platelets &lt; 50 H K/UL . 7 . White Blood Counts ( WBCs ) &lt; 3.0 K/UL . 8 . Active central nervous system ( CNS ) disease . ( The action acupuncture may associate central nervous system activity , patient CNS pathology may respond differently treatment general population . ) 9 . Cardiac pacemaker . 10 . Mental incapacitation significant emotional psychological disorder , opinion investigator , precludes study entry . ( These patient may able cooperate slightly invasive procedure data collection process . ) 11 . Currently pregnant lactating female . ( Certain acupuncture application report stimulate uterine contraction may alter lactation . ) 12 . Chronic alcohol use clinically estimate patient 's physician . 13 . History diabetic neuropathy neuropathy relate HIV . 14 . Previous acupuncture treatment indication within 30 day enrollment . 15 . Active treatment lymphoma , nonHodgkin 's lymphoma multiple myeloma . 16 . Planned actual change type medication could affect symptom related peripheral neuropathy ( PN ) . Note : Minor adjustment current medication time enrollment allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Myeloma</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>MM</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>NHL</keyword>
	<keyword>Acupuncture</keyword>
	<keyword>Treatment-induced Peripheral Neuropathy</keyword>
	<keyword>Thalidomide</keyword>
	<keyword>Bortezomib</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Peripheral Neuropathy</keyword>
</DOC>